Compare Aurora Cannabis Inc (ACB) vs ProShares Ultra Bitcoin ETF (BITU) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

BITU trades at $9.48, up 7.36% in the last 24 hours, with a bullish technical signal but bearish moving averages. The stock faces structural challenges as a leveraged ETF, with key financial ratios like P/E and P/S unavailable. Recent news highlights underperformance relative to Bitcoin due to daily rebalancing decay, with Seeking Alpha rating it a Hold on June 16, 2026.

Outlook remains cautious due to BITU's leveraged structure and volatility decay risks. Investment opportunities are limited to short-term tactical plays during clear bull markets, but long-term holders face significant erosion. Primary risks include ETF mechanics, Bitcoin price dependency, and investor sentiment shifts amid crypto volatility.